Crawford Investment Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102M Sell
415,868
-17,947
-4% -$4.18M 1.74% 15
2025
Q4
$89.8M Buy
433,815
+1,820
+0.4% +$360K 1.49% 22
2025
Q3
$80.1M Buy
431,995
+2,516
+0.6% +$431K 1.33% 28
2025
Q2
$65.6M Sell
429,479
-2,640
-0.6% -$406K 1.15% 31
2025
Q1
$71.7M Sell
432,119
-4,937
-1% -$772K 1.27% 28
2024
Q4
$63.2M Sell
437,056
-11,054
-2% -$1.71M 1.14% 35
2024
Q3
$72.6M Buy
448,110
+4,909
+1% +$782K 1.24% 31
2024
Q2
$64.8M Sell
443,201
-176,802
-29% -$26.3M 1.23% 32
2024
Q1
$98.1M Buy
620,003
+14,069
+2% +$2.24M 1.83% 14
2023
Q4
$95M Sell
605,934
-5,036
-0.8% -$772K 1.9% 11
2023
Q3
$95.2M Buy
610,970
+981
+0.2% +$162K 2.06% 10
2023
Q2
$101M Buy
609,989
+1,368
+0.2% +$221K 2.05% 11
2023
Q1
$94.3M Sell
608,621
-10,457
-2% -$1.69M 2.01% 11
2022
Q4
$109M Sell
619,078
-6,182
-1% -$1.07M 2.35% 9
2022
Q3
$102M Buy
625,260
+8,314
+1% +$1.41M 2.41% 7
2022
Q2
$110M Sell
616,946
-30,176
-5% -$5.38M 2.42% 5
2022
Q1
$115M Sell
647,122
-3,940
-0.6% -$670K 2.22% 7
2021
Q4
$111M Buy
651,062
+12,030
+2% +$1.97M 2.12% 9
2021
Q3
$103M Buy
639,032
+5,099
+0.8% +$870K 2.11% 9
2021
Q2
$104M Buy
633,933
+33,829
+6% +$5.6M 2.11% 10
2021
Q1
$98.6M Buy
600,104
+8,339
+1% +$1.35M 2.22% 9
2020
Q4
$93.1M Buy
591,765
+185
+0% +$27.3K 2.3% 9
2020
Q3
$88.1M Buy
591,580
+4,183
+0.7% +$619K 2.4% 10
2020
Q2
$82.6M Buy
587,397
+5,954
+1% +$868K 2.37% 9
2020
Q1
$76.2M Sell
581,443
-3,188
-0.5% -$452K 2.56% 5
2019
Q4
$85.3M Buy
584,631
+7,295
+1% +$989K 2.2% 11
2019
Q3
$74.7M Buy
577,336
+15,324
+3% +$2.02M 2.07% 12
2019
Q2
$78.3M Buy
562,012
+5,018
+0.9% +$695K 2.2% 10
2019
Q1
$77.9M Buy
556,994
+900
+0.2% +$121K 2.32% 9
2018
Q4
$71.8M Sell
556,094
-359
-0.1% -$50.1K 2.43% 7
2018
Q3
$76.9M Buy
556,453
+4,435
+0.8% +$589K 2.35% 7
2018
Q2
$67M Sell
552,018
-11,334
-2% -$1.41M 2.13% 13
2018
Q1
$72.2M Sell
563,352
-32,512
-5% -$4.39M 2.28% 9
2017
Q4
$83.3M Sell
595,864
-16,334
-3% -$2.28M 2.59% 4
2017
Q3
$79.6M Buy
612,198
+10,221
+2% +$1.35M 2.58% 6
2017
Q2
$79.6M Sell
601,977
-9,467
-2% -$1.21M 2.74% 4
2017
Q1
$76.2M Buy
611,444
+9,494
+2% +$1.13M 2.7% 5
2016
Q4
$69.4M Sell
601,950
-37,883
-6% -$4.38M 2.51% 9
2016
Q3
$75.6M Sell
639,833
-2,100
-0.3% -$255K 2.77% 5
2016
Q2
$77.9M Buy
641,933
+5,306
+0.8% +$603K 3.09% 1
2016
Q1
$68.9M Sell
636,627
-17,215
-3% -$1.78M 2.89% 4
2015
Q4
$67.2M Sell
653,842
-56,018
-8% -$5.63M 2.96% 4
2015
Q3
$66.3M Sell
709,860
-28,633
-4% -$2.77M 2.89% 4
2015
Q2
$72M Sell
738,493
-15,077
-2% -$1.51M 2.73% 5
2015
Q1
$75.8M Buy
753,570
+15,246
+2% +$1.55M 2.74% 8
2014
Q4
$77.2M Sell
738,324
-13,450
-2% -$1.42M 2.72% 9
2014
Q3
$80.1M Buy
751,774
+5,431
+0.7% +$563K 2.89% 6
2014
Q2
$78.1M Sell
746,343
-27,011
-3% -$2.73M 2.76% 7
2014
Q1
$76M Sell
773,354
-28,163
-4% -$2.61M 2.76% 8
2013
Q4
$73.4M Sell
801,517
-10,569
-1% -$974K 2.69% 9
2013
Q3
$70.4M Sell
812,086
-11,075
-1% -$994K 2.79% 4
2013
Q2
$70.7M Buy
+823,161
New +$69.9M 2.92% 2

Other funds holding JNJ

Crawford Investment Counsel's JNJ Position: Q1 2026 in Review

Crawford Investment Counsel reduced its Johnson & Johnson (JNJ) stake by 4.1% in Q1 2026, selling an estimated $4.18M and leaving 415,868 shares worth $102M. The position accounts for 1.74% of the portfolio, ranked #15.

Crawford Investment Counsel first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $115M in Q1 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Crawford Investment Counsel held 415,868 shares of Johnson & Johnson worth $102M as of Q1 2026.
  • Crawford Investment Counsel sold 17,947 Johnson & Johnson shares in Q1 2026, an estimated $4.18M.
  • Johnson & Johnson made up 1.74% of Crawford Investment Counsel's portfolio in Q1 2026, its #15 holding.
  • Crawford Investment Counsel first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Crawford Investment Counsel's Johnson & Johnson position peaked at $115M in Q1 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.